Literature DB >> 8548503

YY1 and Sp1 transcription factors bind the human transferrin gene in an age-related manner.

G S Adrian1, E Seto, K S Fischbach, E V Rivera, E K Adrian, D C Herbert, C A Walter, F J Weaker, B H Bowman.   

Abstract

The iron-binding protein transferrin has major roles in transporting, delivering, and sequestering ferric ions acquired by body tissues. Yet, during aging, serum transferrin levels decrease in humans. Likewise, in transgenic mice carrying chimeric human transferrin transgenes, liver expression of transferrin transgenes decreases with age. The aging regulation is due to decreased gene transcription. Electrophoretic mobility shift assays and antibody-recognition have revealed the binding of 5' regulatory elements of the human transferrin gene by three YY1 proteins, called YY1, YY1-a, and YY1-b, and an Sp1-a transcription factor. An age-related increase in YY1-a and YY1-b binding activities and a decrease in Sp1-like binding activity were shown. Since Sp1 is a positive transcription factor and YY1 can be a negative transcription factor, the alterations in their binding with age could cause the decreased transcription of the human transferrin transgene, and also the age-related decreased serum transferrin levels in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8548503     DOI: 10.1093/gerona/51a.1.b66

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  19 in total

1.  Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.

Authors:  Susanne U Mertens-Talcott; Giuliana D Noratto; Xiangrong Li; Gabriela Angel-Morales; Michele C Bertoldi; Stephen Safe
Journal:  Mol Carcinog       Date:  2012-03-07       Impact factor: 4.784

2.  Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses.

Authors:  Wayne Chadwick; Yu Zhou; Sung-Soo Park; Liyun Wang; Nicholas Mitchell; Matthew D Stone; Kevin G Becker; Bronwen Martin; Stuart Maudsley
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

3.  Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.

Authors:  Satya S Pathi; Ping Lei; Sandeep Sreevalsan; Gayathri Chadalapaka; Indira Jutooru; Stephen Safe
Journal:  Nutr Cancer       Date:  2011-09-15       Impact factor: 2.900

4.  Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sandeep Sreevalsan; Satya Pathi; Kyounghyun Kim; Candy Chen; Lisa Crose; Corinne Linardic; Stephen Safe
Journal:  Int J Cancer       Date:  2012-08-03       Impact factor: 7.396

5.  REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER.

Authors:  Sandeep Sreevalsan; Stephen Safe
Journal:  Curr Colorectal Cancer Rep       Date:  2013-12

6.  Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Robert Burghardt; Stephen Safe
Journal:  Mol Cancer Res       Date:  2010-04-20       Impact factor: 5.852

7.  Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1.

Authors:  Y L Yao; B R Dupont; S Ghosh; Y Fang; R J Leach; E Seto
Journal:  Nucleic Acids Res       Date:  1998-08-15       Impact factor: 16.971

8.  Transcription factors Sp1 and Hif2α mediate induction of the copper-transporting ATPase (Atp7a) gene in intestinal epithelial cells during hypoxia.

Authors:  Liwei Xie; James F Collins
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

9.  MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.

Authors:  Stephen Safe
Journal:  Curr Pharmacol Rep       Date:  2015-01-11

10.  The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.

Authors:  Sandeep Sreevalsan; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2013-09-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.